Terms: = Thyroid cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
26 results:
1. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
2. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
4. Blocking CDK7-Mediated notch1-cMYC Signaling Attenuates cancer Stem Cell Activity in Anaplastic thyroid cancer.
Doolittle WKL; Zhao L; Cheng SY
Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
[No Abstract] [Full Text] [Related]
5. The role of microRNA in cisplatin resistance or sensitivity.
Wang S; Li MY; Liu Y; Vlantis AC; Chan JY; Xue L; Hu BG; Yang S; Chen MX; Zhou S; Guo W; Zeng X; Qiu S; van Hasselt CA; Tong MC; Chen GG
Expert Opin Ther Targets; 2020 Sep; 24(9):885-897. PubMed ID: 32559147
[TBL] [Abstract] [Full Text] [Related]
6. Effect of miR‑449a‑mediated Notch signaling pathway on the proliferation, apoptosis and invasion of papillary thyroid carcinoma cells.
Hou Y; Feng F; Yang R
Oncol Rep; 2020 Feb; 43(2):471-480. PubMed ID: 31894345
[TBL] [Abstract] [Full Text] [Related]
7. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
[TBL] [Abstract] [Full Text] [Related]
8. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast cancer Stemness by Targeting
Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
[TBL] [Abstract] [Full Text] [Related]
9. Notch signaling pathway regulates CD4
Yang L; Zhao KL; Qin L; Ji DX; Zhang B; Zheng PF; Qin YM
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988066
[TBL] [Abstract] [Full Text] [Related]
10. Major vault protein is a direct target of notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells.
Xiao YS; Zeng D; Liang YK; Wu Y; Li MF; Qi YZ; Wei XL; Huang WH; Chen M; Zhang GJ
Cancer Lett; 2019 Jan; 440-441():156-167. PubMed ID: 30336197
[TBL] [Abstract] [Full Text] [Related]
11. CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.
Wong EHC; Tetter N; Tzankov A; Muller L
Head Neck; 2018 Jan; 40(1):E1-E4. PubMed ID: 29120527
[TBL] [Abstract] [Full Text] [Related]
12. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway.
Zhang J; Yu K; Han X; Zhen L; Liu M; Zhang X; Ren Y; Shi J
Mol Med Rep; 2018 Jan; 17(1):1321-1325. PubMed ID: 29115554
[TBL] [Abstract] [Full Text] [Related]
13. The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma.
Maroof H; Islam F; Ariana A; Gopalan V; Lam AK
Endocrine; 2017 Oct; 58(1):153-166. PubMed ID: 28840508
[TBL] [Abstract] [Full Text] [Related]
14. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
[TBL] [Abstract] [Full Text] [Related]
15. Suberoyl bis-hydroxamic acid activates notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53.
Li J; Zheng X; Gao M; Zhao J; Li Y; Meng X; Qian B; Li J
Oncol Rep; 2017 Jan; 37(1):458-464. PubMed ID: 28004113
[TBL] [Abstract] [Full Text] [Related]
16. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
[TBL] [Abstract] [Full Text] [Related]
17. Novel approaches in anaplastic thyroid cancer therapy.
Hsu KT; Yu XM; Audhya AW; Jaume JC; Lloyd RV; Miyamoto S; Prolla TA; Chen H
Oncologist; 2014 Nov; 19(11):1148-55. PubMed ID: 25260367
[TBL] [Abstract] [Full Text] [Related]
18. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of notch1 signaling and suppresses cell growth.
Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
[TBL] [Abstract] [Full Text] [Related]
19. Chrysin activates notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
[TBL] [Abstract] [Full Text] [Related]
[Next]